-
EP2273989
European procedure
- EP About this file
- EP Legal status
- EP Federated register
- EP Event history
- EP Citations
- EP Patent family
- EP All documents
Extract from the Register of European Patents
EP About this file: EP2273989
| EP2273989 - COMBINATION THERAPY FOR THE TREATMENT OF BACTERIAL INFECTIONS [Right-click to bookmark this link] | Status | The application is deemed to be withdrawn Status updated on 28.03.2014 Database last updated on 15.06.2024 | Most recent event Tooltip | 28.03.2014 | Application deemed to be withdrawn | published on 30.04.2014 [2014/18] | Applicant(s) | For all designated states Interface Biologics Inc. 300-101 College Street Mars South Tower Toronto, Ontario M5G 1L7 / CA | [2011/03] | Inventor(s) | 01 /
LARONDE, Frank 902-218 Queen's Quay West Toronto, Ontario M5J 2Y6 / CA | 02 /
CHEN, Hanje 102 Risebrough Avenue Toronto, Ontario M2M 2E3 / CA | 03 /
SINNADURAI, Selva 301 Washburn Way Unit 10 Scarborough, Ontario M1B 1K4 / CA | [2011/03] | Representative(s) | Lahrtz, Fritz, et al Patentanwälte Isenbruck Bösl Hörschler PartG mbB Prinzregentenstraße 68 81675 München / DE | [N/P] |
| Former [2011/03] | Lahrtz, Fritz, et al Isenbruck Bösl Hörschler LLP Patentanwälte Prinzregentenstrasse 68 81675 München / DE | Application number, filing date | 09731462.9 | 07.04.2009 | [2011/03] | WO2009CA00446 | Priority number, date | US20080123231P | 07.04.2008 Original published format: US 123231 P | [2011/03] | Filing language | EN | Procedural language | EN | Publication | Type: | A1 Application with search report | No.: | WO2009124386 | Date: | 15.10.2009 | Language: | EN | [2009/42] | Type: | A1 Application with search report | No.: | EP2273989 | Date: | 19.01.2011 | Language: | EN | The application published by WIPO in one of the EPO official languages on 15.10.2009 takes the place of the publication of the European patent application. | [2011/03] | Search report(s) | International search report - published on: | CA | 15.10.2009 | (Supplementary) European search report - dispatched on: | EP | 03.04.2013 | Classification | IPC: | A61K31/155, A01N43/80, A01N47/44, A01P1/00, A61K31/4174, A61K31/43, A61K31/496, A61K31/635, A61K31/7036, A61K38/14, A61L15/46, A61L15/64, A61L2/16, A61L27/54, A61L27/58, A61L29/16, A61L31/14, A61L31/16, A61P31/04, A61P31/10, C08L101/02 | [2011/03] | CPC: |
A61L27/54 (EP,US);
A61K31/155 (EP,US);
A61K31/4174 (EP,US);
A61K31/43 (EP,US);
A61K31/496 (EP,US);
A61K31/635 (EP,US);
A61K31/7036 (EP,US);
A61K38/14 (EP,US);
A61L15/46 (EP,US);
A61L17/005 (EP,US);
A61L2/16 (EP,US);
A61L29/16 (EP,US);
A61L31/16 (EP,US);
A61P31/04 (EP);
A61P31/10 (EP);
A61L2300/206 (EP,US);
A61L2300/404 (EP,US);
A61L2300/406 (EP,US);
| C-Set: |
A61K31/155, A61K2300/00 (US,EP);
A61K31/4174, A61K2300/00 (US,EP);
A61K31/43, A61K2300/00 (US,EP);
A61K31/496, A61K2300/00 (US,EP);
A61K31/635, A61K2300/00 (EP,US);
A61K31/7036, A61K2300/00 (EP,US); | Designated contracting states | AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, SE, SI, SK, TR [2011/03] | Title | German: | KOMBINATIONSTHERAPIE ZUR BEHANDLUNG VON BAKTERIELLEN INFEKTIONEN | [2011/03] | English: | COMBINATION THERAPY FOR THE TREATMENT OF BACTERIAL INFECTIONS | [2011/03] | French: | POLYTHÉRAPIE POUR LE TRAITEMENT DES INFECTIONS BACTÉRIENNES | [2011/03] | Entry into regional phase | 05.11.2010 | National basic fee paid | 05.11.2010 | Search fee paid | 05.11.2010 | Designation fee(s) paid | 05.11.2010 | Examination fee paid | Examination procedure | 05.11.2010 | Amendment by applicant (claims and/or description) | 05.11.2010 | Examination requested [2011/03] | 14.12.2012 | Observations by third parties | 30.10.2013 | Application deemed to be withdrawn, date of legal effect [2014/18] | 06.12.2013 | Despatch of communication that the application is deemed to be withdrawn, reason: reply to the communication from the examining division not received in time [2014/18] | Fees paid | Renewal fee | 25.04.2011 | Renewal fee patent year 03 | 25.04.2012 | Renewal fee patent year 04 | 29.04.2013 | Renewal fee patent year 05 |
| Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
| Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Documents cited: | Search | [A]WO9637191 (ALCON LAB INC [US], et al) [A] 1-3,5-7,13-15 * page 1, lines 4-6 * * page 2, lines 5-10 * * page 3, lines 10-16 *; | [A]WO03000303 (UNIV COLUMBIA [US], et al) [A] 1-3,5-7,13-15 * page 13; table III * * page 13, line 16 - page 14, line 4 *; | HUP0302031 [ ] (LAVET GYOGYSZERGYARTO ES SZOLG [HU]); | [AD]WO2005110485 (INTERFACE BIOLOGICS INC [CA], et al) [AD] 1-3,5-7,13-15 * page 6, line 25 - page 10, line 2 * * page 11, line 14 - page 13, line 19 * * page 15, line 17 - page 16, lines 9, 21-23 *; | [A]WO2006019654 (BOSTON SCIENT SCIMED INC [US], et al) [A] 1-3,5-7,13-15 * page 8, lines 1-8 * * page 11, lines 7-15 * * claims 1, 8, 9, 10, 11, 12, 20-24 *; | HU226731 [ ] (LAVET GYOGYSZERGYARTO ES SZOLG [HU]) [ ] * page 2; table 1 * * page 3; table 2 *; | [X] - Z. WINTER-ALLISON ET AL., "ACANTHOMOEBA INFECTION AS A CAUSE OF SEVERE KERATITIS IN A SOFT CONTACT LENS WEARER IN JAMAICA", THE AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE, (2005), vol. 73, no. 1, pages 92 - 94, XP002693486 [X] 1-3 * abstract * * page 92, column r, paragraph 4 * | [A] - CA, CHEMICAL ABSTRACTS SERVICE, COLUMBUS, OHIO, US, URL: STN-International, XP002693482 [A] 1-3,5-7,13-15 * abstract * * index terms "IT" * | [A] - HAWSER S ET AL, "AR-100, a novel diaminopyrimidine compound: Activity against selected Gram-positive and Gram-negative bacterial pathogens and synergy with other antibiotics.", BIOSIS, BIOSCIENCES INFORMATION SERVICE, PHILADELPHIA, PA, US, (2002), Database accession no. PREV200300338524, XP002693483 [A] 1-3,5-7,13-15 * abstract * | [ ] - ABSTRACTS OF THE INTERSCIENCE CONFERENCE ON ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 42ND INTERSCIENCE CONFERENCE ON ANTIMICROBIAL AGENTS AND CHEMOTHERAPY; SAN DIEGO, CA, USA; SEPTEMBER 27-30, 2002, (2002), vol. 42, page 228 | [A] - MARKS M I, "In vitro activity of clindamycin and other antimicrobials against gram-positive bacteria and Hemophilus influenzae.", MEDLINE, US NATIONAL LIBRARY OF MEDICINE (NLM), BETHESDA, MD, US, (19750125), Database accession no. NLM234287, XP002693484 [A] 1-3,5-7,13-15 * abstract * | [ ] - MARKS M I, "In vitro activity of clindamycin and other antimicrobials against gram-positive bacteria and Hemophilus influenzae.", CANADIAN MEDICAL ASSOCIATION JOURNAL 25 JAN 1975, (19750125), vol. 112, no. 2, ISSN 0008-4409, pages 170 - 173 | [A] - BRANDER P ET AL, "The in vitro activity of ampicillin, amoxicillin, cephalexin, nitrofurantoin, sulphadiazine and trimethoprim against Streptococcus agalactiae isolated from urinary and other infections.", MEDLINE, US NATIONAL LIBRARY OF MEDICINE (NLM), BETHESDA, MD, US, (198209), Database accession no. NLM6757138, XP002693485 [A] 1-3,5-7,13-15 * abstract * DOI: http://dx.doi.org/10.1007/BF01640879 | [ ] - BRANDER P ET AL, "The in vitro activity of ampicillin, amoxicillin, cephalexin, nitrofurantoin, sulphadiazine and trimethoprim against Streptococcus agalactiae isolated from urinary and other infections.", INFECTION 1982 SEP-OCT, (198209), vol. 10, no. 5, ISSN 0300-8126, pages 299 - 302 | International search | [X]CA2438346 (HERAEUS KULZER GMBH & CO KG [DE]); | [X]CA2539868 (PESHOFF MICKEY L [US]); | [X]CA2417389 (UNIV RUTGERS [US]); | [Y]CA2243649 (SANTERRE J PAUL [CA], et al); | [Y]CA2467321 (LI MEI [CA], et al); | [Y]CA2611577 (FOAMIX LTD [IL]); | [Y] - CRAIG ET AL., MODERN PHARMACOLOGY, (1994), XP008143730 | other | EP0608308 | - NOAH, Compendium of Data Sheets for Veterinary products 2000-2001, BECCLES, CLOWES W. LTD, (2000), pages 440 - 443, XP003032103 | - "Make your own chlorhexidine shampoo", INGLIS S. ET AL, Compendium of Veterinary Products, BAYLEY A.J., (2005), XP003032102 |